WebMD (WBMD -17.4%) plunges after reporting preliminary Q2 revenue of $112M and EPS of -$0.12,...


WebMD (WBMD -17.4%) plunges after reporting preliminary Q2 revenue of $112M and EPS of -$0.12, below a consensus of $115.1M and -$0.10. It's also now guiding for 2012 revenue of $455M-$480M and an operating loss of $12.4M-$23.4M, compared with prior guidance for revenue of $500M-$535M and net income of $2.8M-$19.9M. WebMD blames soft ad spending from drugmakers, thanks to patent expirations and delayed product launches. Carl Icahn can't be happy.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs